GLP-1 and GIP class drugs have neuroprotective properties in Alzheimer's and Parkinson's disease

Related

• Alzheimer's & Dementia·7 Oct 2026

  Brain receptor gene activity linked to lower Alzheimer’s risk

  

• Neurology Genetics·4 Oct 2026

  GLP-1 receptor agonists link to lower stroke and Alzheimer risk

• Diabetes & Vascular Disease Research·4 Oct 2026

  SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs

• Journal of Neurochemistry·2 Oct 2026

  Pan-AMPK activator MK-8722 improves spatial memory in Alzheimer's model mice